U.S. PHARMACOPEIA

Search USP29  
Triprolidine and Pseudoephedrine Hydrochlorides Oral Solution
Former title:Triprolidine and Pseudoephedrine Hydrochlorides Syrup
» Triprolidine and Pseudoephedrine Hydrochlorides Oral Solution contains not less than 90.0 percent and not more than 110.0 percent of the labeled amounts of triprolidine hydrochloride (C19H22N2·HCl·H2O) and pseudoephedrine hydrochloride (C10H15NO·HCl).
Packaging and storage— Preserve in tight, light-resistant containers.
Identification—
A: The retention times of the major peaks in the chromatogram of the Assay preparation correspond to those in the chromatogram of the Standard preparation, as obtained in the Assay.
B: Transfer 10 mL of Oral Solution to a suitable glass-stoppered tube, add 10 mL of ether and 2 mL of 1 N sodium hydroxide, shake for 5 minutes, and allow the layers to separate. The ether layer is the test solution. Prepare a Standard solution in water of USP Pseudoephedrine Hydrochloride RS and USP Triprolidine Hydrochloride RS having known concentrations of 6 mg per mL and 250 µg per mL, respectively. Separately apply 10-µL portions of the test solution and the Standard solution to a suitable thin-layer chromatographic plate (see Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel mixture. Allow the spots to dry, and develop the chromatogram in a solvent system consisting of a mixture of butyl alcohol, glacial acetic acid, and water (8:2:2) until the solvent front has moved about three-fourths of the length of the plate. Remove the plate, mark the solvent front, allow the solvent to evaporate, and examine the plate under short-wavelength and long-wavelength UV light: the RF values of the principal spots obtained from the test solution correspond to those obtained from the Standard solution.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay—
Mobile phase— Prepare a filtered and degassed mixture of alcohol and 0.40% ammonium acetate solution (17:3). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Dissolve accurately weighed quantities of USP Pseudoephedrine Hydrochloride RS and USP Triprolidine Hydrochloride RS in 0.01 N hydrochloric acid, and dilute quantitatively and stepwise with 0.01 N hydrochloric acid to obtain a solution having known concentrations of about 1.2 mg of USP Pseudoephedrine Hydrochloride RS per mL and about 0.05 mg of anhydrous USP Triprolidine Hydrochloride RS per mL, and filter.
Assay preparation— Transfer an accurately measured volume of Oral Solution, equivalent to about 60 mg of pseudoephedrine hydrochloride, to a 50-mL volumetric flask, dilute with 0.01 N hydrochloric acid to volume, and mix.
Chromatographic system (see Chromatography 621) The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 25-cm column that contains packing L3. The flow rate is about 1.5 mL per minute. Chromatograph replicate injections of the Standard preparation, and record the peak responses as directed for Procedure: the relative standard deviation is not more than 2.0%; and the resolution factor between triprolidine and pseudoephedrine is not less than 2.0. The tailing factor for the triprolidine peak is not more than 2.0, and the pseudoephedrine peak is not more than 2.0.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. The relative retention times are about 0.68 for pseudoephedrine hydrochloride and 1.0 for triprolidine hydrochloride. Calculate the quantity, in mg, of pseudoephedrine hydrochloride (C10H15NO·HCl) in the portion of Oral Solution taken by the formula:
50C(rU / rS),
in which C is the concentration, in mg per mL, of USP Pseudoephedrine Hydrochloride RS in the Standard preparation; and rU and rS are the peak responses for pseudoephedrine hydrochloride obtained from the Assay preparation and the Standard preparation, respectively. Calculate the quantity, in mg, of triprolidine hydrochloride (C19H22N2·HCl·H2O) in the portion of Oral Solution taken by the formula:
(332.88 / 314.86)(50C)(rU / rS),
in which 332.88 and 314.86 are the molecular weights of triprolidine hydrochloride monohydrate and anhydrous triprolidine hydrochloride, respectively; C is the concentration, in mg per mL, calculated on the anhydrous basis, of USP Triprolidine Hydrochloride RS in the Standard preparation; and rU and rS are the peak responses for triprolidine hydrochloride obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Staff Liaison : Daniel K. Bempong, Ph.D., Scientist
Expert Committee : (MDPS05) Monograph Development-Pulmonary and Steroids
USP29–NF24 Page 2218
Pharmacopeial Forum : Volume No. 28(2) Page 394
Phone Number : 1-301-816-8143